Pharma Focus Asia
KP - Choose our fully recyclable blister films

Ambient Stable Biologics - Stable Aqueous Erythropoietin


Erythropoietin (EPO) is known to aggregate under heat stress, which prevents storage of liquid compositions at ambient temperature. The key challenge of this study was to demonstrate that the application of the ArestatT tools can reduce significantly aggregation of EPO at an elevated temperature, compared with a marketed liquid formulation

ArestatT solution

A liquid EPO product was reformulated and the key parameters, such as pH, osmolality and the nature of the surfactant were kept unchanged in the new formulation. The critical change was the nature of the buffering species, which were selected to ensure minimal proton exchange between the protein molecule and excipients, and to minimise hydrophobic interactions. Incubation of the currently marketed EPO formulation at 40?C for 24 weeks resulted in considerable (>50%) high molecular weight species formation (HMWS, measured by size-exclusion chromatography). In contrast, the reformulated EPO, using the ArestatT alternative buffering species, showed virtually no aggregation following the same treatment.

The rate of aggregation of EPO (82 ?g/ml) at 40&deh;C in ArestatT formulation compared with the control.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayMerck - Mobius® productsThermo Fisher Scientific - Peptones5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024